Security vendors and their customers have spent considerable time debating where to draw the line between “legitimate” AI agents and “malicious” bots. A 31-day campaign against a major consumer ...
RECIST v1.1 in patients with platinum-resistant ovarian cancer (“PROC”) who progressed on a median of 7 prior lines of therapy ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する